TY - CHAP
T1 - Biomaterial Design for Human ESCs and iPSCs on Feeder-Free Culture toward Pharmaceutical Usage of Stem Cells
AU - Higuchi, Akon
AU - Suresh Kumar, S.
AU - Munusamy, Murugan A.
AU - Alarfaj, Abdullah A.
N1 - Publisher Copyright:
© 2015 Scrivener Publishing LLC. All rights reserved.
PY - 2015/7/3
Y1 - 2015/7/3
N2 - This chapter describes recent developments of natural and synthetic biomaterials to support the propagation of human pluripotent stem cells (hPSCs), including human embryonic stem cells (hESCs) and induced pluripotent stem cells (hiPSCs), while maintaining pluripotency in feeder-free cultures. hPSCs are differentiated into any kind of tissue cells in our body, which will be used as pharmaceuticals as cell therapy. The development of methods for culturing these cells without using mouse embryonic fibroblasts (MEFs) as a feeder layer will enable more reproducible culture conditions and reduce the risk of xenogenic contaminants when used in pharmaceuticals. The combination of human ECM proteins or cell adhesion molecules and synthetic biomaterials with well-designed surfaces and/or structures (e.g., scaffolds, hydrogels, microcarriers, microcapsules, or microfibers) in the presence of a chemically defined medium containing recombinant growth factors would offer a xeno-free alternative to feeder cells for culturing hPSCs and maintaining their pluripotency.
AB - This chapter describes recent developments of natural and synthetic biomaterials to support the propagation of human pluripotent stem cells (hPSCs), including human embryonic stem cells (hESCs) and induced pluripotent stem cells (hiPSCs), while maintaining pluripotency in feeder-free cultures. hPSCs are differentiated into any kind of tissue cells in our body, which will be used as pharmaceuticals as cell therapy. The development of methods for culturing these cells without using mouse embryonic fibroblasts (MEFs) as a feeder layer will enable more reproducible culture conditions and reduce the risk of xenogenic contaminants when used in pharmaceuticals. The combination of human ECM proteins or cell adhesion molecules and synthetic biomaterials with well-designed surfaces and/or structures (e.g., scaffolds, hydrogels, microcarriers, microcapsules, or microfibers) in the presence of a chemically defined medium containing recombinant growth factors would offer a xeno-free alternative to feeder cells for culturing hPSCs and maintaining their pluripotency.
KW - Biomaterial
KW - Cell culture
KW - Differentiation
KW - Embryonic stem cells
KW - Extracellular matrix
KW - Induced pluripotent stem cells
KW - Pluripotency
KW - Vitronectin
UR - http://www.scopus.com/inward/record.url?scp=84969196436&partnerID=8YFLogxK
U2 - 10.1002/9781119041375.ch6
DO - 10.1002/9781119041375.ch6
M3 - 篇章
AN - SCOPUS:84969196436
SN - 9781119041344
VL - 1
SP - 167
EP - 214
BT - Structure and Chemistry
PB - wiley
ER -